Lantheus Medical Imaging
Clinical trials sponsored by Lantheus Medical Imaging, explained in plain language.
A company developing diagnostic imaging agents.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New scan could reveal hidden spread of prostate cancer Results expected Sep 2026 (estimated)
- New radiation drug targets bone cancer cells directly Results expected Aug 2027 (estimated)
-
Can a special PET scan change the course of prostate cancer?
Diagnosis OngoingResearchers are running a registry to see how a PET scan using PYLARIFY (piflufolastat F18) affects real-world care for men with prostate cancer. The study will follow 500 men for up to 5 years, collecting data every 6 months on their diagnosis, treatment, and outcomes. The goal …
Sponsor: Lantheus Medical Imaging • Aim: Diagnosis
Last updated Sep 17, 2026 00:00 UTC
-
Kidney cancer scan study pulled before it even started
Diagnosis CancelledThis study aimed to see if a special PET/CT scan using a radioactive tracer called piflufolastat F 18 could better detect whether clear cell renal cell carcinoma (a type of kidney cancer) has spread. Researchers planned to enroll adults with suspected or high-risk metastatic dise…
Phase 2/3 • Sponsor: Lantheus Medical Imaging • Aim: Diagnosis
Last updated Jun 27, 2026 08:03 UTC
-
New scan could reveal hidden spread of prostate cancer
Diagnosis OngoingThis study is testing whether a special PET scan using PYLARIFY can find prostate cancer that has spread beyond the prostate in men with favorable intermediate risk cancer. About 274 men will receive one injection and scan, then be followed for up to a year. The goal is to see if…
Phase 4 • Sponsor: Lantheus Medical Imaging • Aim: Diagnosis
Last updated Jun 26, 2026 15:36 UTC